MindRank raises $52.0M Series B (Jul 2026)
$52.0M
$52M Series BGenerated social card
Headline
MindRank Closes $52M Series B for GLP-1 Drug - AllSci
About
MindRank is a biotechnology company focused on developing GLP-1 drugs. This funding round will help advance their innovative treatments aimed at addressing metabolic disorders. The $52 million raised will support their clinical trials and further research.
Article summary
MindRank Closes $52M Series B for GLP-1 Drug AllSci
Investors
Related rounds
| Jul 05, 2026 | Axten Hospitals | $301K | Seed | India |
| Jul 04, 2026 | Heatronics | $216K | Seed | India |
| Jul 04, 2026 | Ivory | $1.0M | Seed | India |
| Jul 03, 2026 | Temple | $54.0M | unknown | India |